DS
DRW Securities’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.68M | Sell |
53,331
-82,069
| -61% | -$5.66M | 0.08% | 78 |
|
|
2025
Q1 | $9.4M | Buy |
135,400
+117,400
| +652% | +$8.15M | 0.26% | 21 |
|
|
2024
Q4 | $1.55M | Sell |
18,000
-68,444
| -79% | -$5.89M | 0.05% | 122 |
|
|
2024
Q3 | $10.3M | Buy |
86,444
+77,367
| +852% | +$9.21M | 0.29% | 25 |
|
|
2024
Q2 | $1.3M | Buy |
+9,077
| New | +$1.3M | 0.05% | 152 |
|
|
2024
Q1 | – | Sell |
-1,961
| Closed | -$203K | – | 360 |
|
|
2023
Q4 | $203K | Sell |
1,961
-12,539
| -86% | -$1.3M | ﹤0.01% | 229 |
|
|
2023
Q3 | $1.32M | Buy |
14,500
+3,826
| +36% | +$348K | 0.03% | 79 |
|
|
2023
Q2 | $1.73M | Buy |
10,674
+8,064
| +309% | +$1.3M | 0.04% | 69 |
|
|
2023
Q1 | $415K | Sell |
2,610
-26,468
| -91% | -$4.21M | 0.01% | 149 |
|
|
2022
Q4 | $3.94M | Buy |
29,078
+10,860
| +60% | +$1.47M | 0.11% | 19 |
|
|
2022
Q3 | $1.82M | Buy |
18,218
+5,187
| +40% | +$517K | 0.04% | 39 |
|
|
2022
Q2 | $1.45M | Buy |
+13,031
| New | +$1.45M | 0.04% | 38 |
|
|
2020
Q4 | – | Sell |
-3,254
| Closed | -$226K | – | 141 |
|
|
2020
Q3 | $226K | Buy |
+3,254
| New | +$226K | 0.01% | 104 |
|
|
2016
Q4 | – | Sell |
-12,000
| Closed | -$499K | – | 69 |
|
|
2016
Q3 | $499K | Buy |
+12,000
| New | +$499K | 0.03% | 31 |
|
|
2015
Q4 | – | Sell |
-50,000
| Closed | -$2.71M | – | 83 |
|
|
2015
Q3 | $2.71M | Buy |
+50,000
| New | +$2.71M | 0.3% | 9 |
|